Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

<p>Supplementary tables</p>

Saved in:

書目詳細資料
主要作者:	Gwo Yaw Ho (14961416) (author)
其他作者:	Elizabeth L. Kyran (14961419) (author), Justin Bedo (14961422) (author), Matthew J. Wakefield (14952747) (author), Darren P. Ennis (14961425) (author), Hasan B. Mirza (14961428) (author), Cassandra J. Vandenberg (14961431) (author), Elizabeth Lieschke (14961434) (author), Andrew Farrell (14961437) (author), Anthony Hadla (14961440) (author), Ratana Lim (14961443) (author), Genevieve Dall (14961446) (author), James E. Vince (14961449) (author), Ngee Kiat Chua (14961452) (author), Olga Kondrashova (14952696) (author), Rosanna Upstill-Goddard (14961455) (author), Ulla-Maja Bailey (14961458) (author), Suzanne Dowson (14961461) (author), Patricia Roxburgh (14961464) (author), Rosalind M. Glasspool (14961467) (author), Gareth Bryson (14961470) (author), Andrew V. Biankin (14937726) (author), Susanna L. Cooke (9957193) (author), Gayanie Ratnayake (14961473) (author), Orla McNally (14961476) (author), Nadia Traficante (14961479) (author), Anna DeFazio (14952738) (author), S. John Weroha (14961482) (author), David D. Bowtell (14961485) (author), Iain A. McNeish (14932661) (author), Anthony T. Papenfuss (10025621) (author), Clare L. Scott (14952750) (author), Holly E. Barker (14946729) (author)
出版:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Mechanisms Cellular responses to anticancer drugs Genome Biology Gynecological Cancers Ovarian cancer Metabolism Metabolic pathways Preclinical Models Xenograft models Rare Cancers Translational Research
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
由: Evangeline R. Jackson (15558808)
出版: (2025)

Supplementary Data S1 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
由: Namhee Kim (14963603)
出版: (2025)

Supplementary Data S2 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
由: Namhee Kim (14963603)
出版: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
由: Lixuan Wei (14962431)
出版: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
由: Nicole A. Traphagen (16677391)
出版: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
由: Nicole A. Traphagen (16677391)
出版: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
由: Pochung Jordan Chou (14851578)
出版: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
由: Pochung Jordan Chou (14851578)
出版: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
由: Pochung Jordan Chou (14851578)
出版: (2025)

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S5 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S6 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S7 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S8 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
由: Gia-Buu Tran (16437051)
出版: (2025)

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
由: Gia-Buu Tran (16437051)
出版: (2025)

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
由: Gia-Buu Tran (16437051)
出版: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
由: Gia-Buu Tran (16437051)
出版: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
由: Gia-Buu Tran (16437051)
出版: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
由: Yemin Wang (17315078)
出版: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
由: Alyssa C. Flint (16676029)
出版: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
由: Alyssa C. Flint (16676029)
出版: (2025)

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
由: Juliana Navarro-Yepes (17079059)
出版: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
由: Phyllis S.Y. Chong (17141520)
出版: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
由: Phyllis S.Y. Chong (17141520)
出版: (2025)

Table ST1 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
由: Ossia M. Eichhoff (14964145)
出版: (2025)

Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
由: Ossia M. Eichhoff (14964145)
出版: (2025)

Table ST3 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
由: Ossia M. Eichhoff (14964145)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_79m45p1e1rq0b2iiohnnm5eskl